Export opportunities in the life science industry

Exporting life science solutions typically involves delivering pharmaceuticals, medical technologies, biotech products and digital health solutions across markets, supported by clinical evidence, regulatory approval and local partnerships.

  • Pharmaceuticals and advanced therapies
    Swedish companies export innovative drugs, vaccines, biologics and advanced therapies, often supported by strong research and clinical validation, and frequently developed in partnership with global pharmaceutical companies.
  • Medical technology and diagnostics
    Exports include imaging systems, diagnostics, surgical instruments and patient monitoring solutions, typically sold to hospitals and healthcare providers through distributors or direct engagement.
  • Biotech and research tools
    Laboratory equipment, reagents and research platforms are supplied to global pharmaceutical companies, research institutions and laboratories, supporting drug discovery and development worldwide.
  • Digital health and connected care
    Digital solutions such as telehealth, remote monitoring and data-driven diagnostics enable scalable international delivery, although adoption often depends on integration with local healthcare systems.
  • Partnership- and licensing-driven models
    International growth often relies on licensing agreements, co-development partnerships and alliances with global players to access regulatory expertise, distribution and commercial scale.
  • Growing global demand for healthcare solutions
    Ageing populations, chronic diseases and increasing healthcare spending are driving long-term demand for innovative treatments, technologies and services across global markets.

These dynamics shape how companies prioritise markets, position their offerings and structure international expansion.